Product Information
CLOBAZAM 20 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.4793 per EA under NDC 68180015801. Its NADAC has been published 371 times since May 22, 2019.
Strength
20 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180015801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA210545On Market Since
5/8/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 20 MG TABLET has been published 371 times since May 22, 2019, and over the history we have for it it has declined 67.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4793 per EA |
|---|---|
| All-time high | $1.4581 (Jun 12, 2019) |
| All-time low | $0.4061 (Jul 23, 2025) |
| 52-week high | $0.5144 |
| 52-week low | $0.4061 |
| Median price | $0.7032 |
| Average price | $0.7144 |
| Largest weekly change | +78.0% (Aug 23, 2023) |
| Weeks tracked | 371 |
| Tracking since | May 22, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.4793 per EA (NDC 68180015801), effective Jun 24, 2026.
How has the price of CLOBAZAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 67.1%. It has been tracked across 371 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?
Since May 22, 2019, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.4061 (Jul 23, 2025) to a high of $1.4581 (Jun 12, 2019), with a median of $0.7032 per EA.
Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLOBAZAM 20 MG TABLET, but none are currently priced below it.
Who manufactures CLOBAZAM 20 MG TABLET?
CLOBAZAM 20 MG TABLET (NDC 68180015801) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification